On the academic side, Dr. Cohen’s studies in IBD include investigations of both standard and experimental pharmacological therapies, including novel immunomodulatory agents, as well as studies analyzing quality of life and the economics involved in the diagnosis and treatment of IBD.
Dr. Cohen earned his medical degree from Mount Sinai School of Medicine in New York City and completed his residency at Harvard University in Boston. He completed his fellowship in gastroenterology and nutrition at the University of Chicago.
More articles on GI & endoscopy:
5 GI physicians in the news — April 8, 2016
Marriage increases likelihood of screening colonoscopy in men — 5 points
Indomethacin holds no benefit for patients undergoing endoscopic retrograde cholangiopancreatography — 3 points
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
